Analysts note pending earnings as a key directional inflection. Over the last 30 days, the consensus EPS estimate for the current year has increased 2%. What it means is that the sell-side analysts covering AMRN are majorly in agreement that the company will report better earnings than they predicted earlier. Amarin is now in full compliance with all Nasdaq listing requirements and will continue to be listed and traded on Nasdaq. Recent trading placed AMRN stock price at $1.14, with Fibonacci retracement levels signaling possible upward momentum if near-term resistance at $1.18 is breached.